Fundraising Fox

Alain Horvais

Investor

Partner at Kurma Partners

Paris, France

Writes $100K – $5M checks · typically $1.5M

About

Alain Horvais leads a diagnostics fund, with a decade in senior roles at Bio‑Rad and AstraZeneca, a PhD in molecular biology, biotechnology management training and panel expertise scaling complex biomarkers.

Invests in

AI & Machine LearningBiotechHealthtechMedical DevicesRobotics

Experience

  1. Kurma PartnersPartnercurrent2015 — presentParis Area, France
  2. AstraZenecaDiagnostic Team Director2011 — 2014Alderley Park- Macclesfield - UK
  3. Bio-Rad LaboratoriesR&D Manager2001 — 2011Paris Area, France
  4. D-GenosScientific Manager1995 — 2001Angers Area, France

Education

  1. NEOMA Business SchoolMaster's degree, Biotechnology Management1995 — 1996
  2. University of AngersPhD, Molecular Biology1989 — 1993

Skills & more

Assay Development10Molecular Biology6qPCR1FDA2Molecular Diagnostics1PCR9RT-PCRIVDLaboratoryBiotechnology8Drug Discovery1Clinical Development1
+7 moreR&DValidationBiomarkersLifesciencesLife SciencesResearch and Development (R&D)Polymerase Chain Reaction (PCR)

Languages English · French

  • Certification profesionnelle AMF des acteurs de MarchésAutorité des marchés financiers (AMF) – France

From Alain's professional profile.

Colleagues at Kurma Partners

Network6

Investors connected to Alain in public investor directories — a warm-intro map.

Frequently asked questions

Where does Alain Horvais work?
Alain Horvais is Partner at Kurma Partners.
What does Alain Horvais invest in?
Alain Horvais invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices, Robotics.
What check size does Alain Horvais write?
Alain Horvais typically writes checks of $100K – $5M.

Same school

Shared employers